GlassScriptPhysician profile
Preeti Mehta
NPI 1134335946
$5,891.97
in general payments reported to CMS, 2019-2025
34 companies · $44.37 in 2025
The $44.37 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,039 · 2020: $931 · 2021: $1,008 · 2022: $911 · 2023: $1,170 · 2024: $788 · 2025: $44.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,002.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,349.06 | 2019-2024 | |
| Gilead Sciences, INC. | $769.41 | 2019-2024 | Epclusa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $620.04 | 2019-2024 | Xifaxan |
| Janssen Biotech, INC. | $370.48 | 2019-2025 | Stelara, Tremfya, Simponi |
| Pfizer INC. | $340.94 | 2019-2024 | |
| Redhill Biopharma INC. | $278.61 | 2020-2024 | Talicia |
| Takeda Pharmaceuticals U.S.A., INC. | $237.12 | 2019-2024 | Entyvio, Gattex, Eohilia |
| Ironwood Pharmaceuticals, INC | $152.23 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $144.96 | 2021-2023 | Zeposia |
| Daiichi Sankyo INC. | $138.54 | 2019-2024 | Injectafer |
| Intra-Sana Laboratories | $136.05 | 2021-2022 | |
| Allergan, INC. | $135.78 | 2020 | |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Covidien LP | $111.02 | 2019 | |
| Ferring Pharmaceuticals INC. | $110.52 | 2019-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $99.38 | 2020-2023 | |
| Boston Scientific Corporation | $95.25 | 2019-2020 | |
| Braintree Laboratories, INC. | $88.40 | 2019-2024 | Suflave, Sutab |
| Lilly USA, LLC | $78.92 | 2024 | Omvoh |
| Merck Sharp & Dohme LLC | $71.73 | 2019-2022 | |
| Celgene Corporation | $71.02 | 2022-2023 | Zeposia |
| Qol Medical, LLC | $58.82 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $45.10 | 2023 | Dupixent |
| Janssen Pharmaceuticals, INC | $38.00 | 2019 | |
| Endo Pharmaceuticals INC. | $34.04 | 2019 | |
| Shionogi INC | $28.62 | 2019 | |
| Intercept Pharmaceuticals, INC. | $23.12 | 2023 | Ocaliva |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.83 | 2023 | Cyltezo |
| Genzyme Corporation | $21.01 | 2023 | |
| Concordia Pharmaceuticals INC. | $20.95 | 2019 | |
| Janssen Scientific Affairs, LLC | $20.37 | 2021 | |
| Alfasigma USA, INC. | $19.01 | 2021 | |
| Axonics, INC. | $18.21 | 2022 | |
| Shire North American Group INC | $17.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preeti Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.